SCHIZOPHRENIA IS A FACTOR INCREASING THE RISKS OF METABOLIC SYNDROME DEVELOPMENT. FINDINGS OF THE RESEARCH INVOLVING PAIR SELECTION METHOD
- Authors: Neznanov NG1,2, Martynikhin IA2, Tanyansky DA3, Rotar OP4, Solntsev VN4, Sokolyan NA1, Konradi AO4, Denisyenko AD3
-
Affiliations:
- St.-Petersburg Bekhterev Psychoneurological Research Institute
- St.-Petersburg State Medical University named after I. P. Pavlov
- Institute of The Experimental Medicine of North-West Branch of Russian Academy of Medical Sciences
- Almazov Federal Blood, Heart, And Endocrinology Centr
- Issue: Vol 13, No 3 (2013)
- Pages: 90-96
- Section: Articles
- URL: https://journals.eco-vector.com/MAJ/article/view/9851
- DOI: https://doi.org/10.17816/MAJ13390-96
- ID: 9851
Cite item
Abstract
Keywords
Full Text
About the authors
N G Neznanov
St.-Petersburg Bekhterev Psychoneurological Research Institute; St.-Petersburg State Medical University named after I. P. Pavlov
Email: spbinstb@bekhterev.ru
I A Martynikhin
St.-Petersburg State Medical University named after I. P. Pavlov
D A Tanyansky
Institute of The Experimental Medicine of North-West Branch of Russian Academy of Medical Sciences
O P Rotar
Almazov Federal Blood, Heart, And Endocrinology Centr
V N Solntsev
Almazov Federal Blood, Heart, And Endocrinology Centr
N A Sokolyan
St.-Petersburg Bekhterev Psychoneurological Research Institute
A O Konradi
Almazov Federal Blood, Heart, And Endocrinology Centr
A D Denisyenko
Institute of The Experimental Medicine of North-West Branch of Russian Academy of Medical Sciences
References
- Brown S. Excess mortality of schizophrenia: a meta-analysis // Brit. J. of Psychiatry.-1997.- Vol. 171.- Р. 502-508.
- Newman S. C., Bland R. C. Mortality in a cohort of patients with schizophrenia: a record linkage study // Can. J. Psychiatry.- 1991.- Vol. 36 (4).- Р. 239-245.
- Osby U., Correia N., Brandt L., Ekbom A., Sparen P. Mortality and causes of death in schizophrenia in Stockholm county.- Sweden, 2000.-Vol. 45(1-2).- Р. 21-28.
- McEvoy J., Meyer J., Goff D. et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research.- 2005.- Vol. 80 (1).- Р. 19-32.
- Ford E. S., Giles W. H., Dietz W. H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey // JAMA.- 2002.- Vol. 287.- Р. 356-359.
- Heiskanen T., Niskanen L., Lyytikainen R. et al. Metabolic syndrome in patients with schizophrenia // J. of Clinical Psychiatry.- 2003.-Vol. 64.- Р. 575-579.
- Cohn T., Prud homme D., Streiner D. et al. Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome // Can. J. Psychiatry.- 2004;49.- Р. 753-760.
- De Hert M., van Winkel R., Van Eyck D. et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study // Clin. Pract. Epidemol. Ment. Health.- 2006.- Vol. 27.- Р. 14.
- Капилетти С. Г., Мосолов С. Н., Шафаренко А. А. Частота метаболических расстройств у больных шизофренией, получающих антипсихотическую терапию. Материалы Общероссийской конференции Реализация подпрограммы «Психические расстройства» Федеральной целевой программы «Предупреждение и борьба с социально-значимыми заболеваниями (2007-2011)» Москва 28-30 октября 2008.- М., 2008.- С. 414-416.
- Горобец Л. Н. Нейроэндокринные дисфункции и нейролептическая терапия.- М.: Медпрактика-М, 2007.- 312 с.
- Незнанов Н. Г., Мартынихин И. А., Соколян Н. А. Распространенность метаболического синдрома среди госпитализированных больных параноидной формой шизофрении в Санкт-Петербурге // Тезисы научно-практической конференции «Актуальные проблемы оказания психиатрической помощи в Северо-Западном регионе Российской Федерации».- СПб., 2008.- С. 147-148.
- The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation, 2006, www.idf.org/metabolic_syndrome, website of the International Diabetes Federation.
- Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) // JAMA.- 2001.- Vol. 285.- Р. 2486-2497.
- American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes // J. Clin. Psychiatry.- 2004.- Vol. 65.- Р. 267-272.
- Newcomer J. W., Nasrallah H. A., Loebel A. D. The atypical antipsychotic therapy and metabolic issues national survey: practice patterns and knowledge of psychiatrists // J. Clin. Psychopharmacol.- 2004.- Vol. 24 (5 suppl. 1).- Р. S1-S6.
- Ryan M. С. M., Collins P., Thakore J. H. Impaired fasting glucose tolerance in first-episode, drug naive patients with schizophrenia // Amer. J. of Psychiatry.- 2003.- Vol. 160.- Р. 284-289.
- Thakore J. H., Vlahoos J., MartinA. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia // Int. J. of Obesity Related Metabolic Disorders.- 2002.- Vol. 26.- Р. 137-141.
- Bushe C., Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia // Brit. J. of Psychiatry.- 2004.-Vol. 18, № 4 (suppl. 47).- Р. 67-71.
- La Y. J., Wan C. L., Zhu H. et al. Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients // J. Neural. Transm.- 2007.-Vol. 114 (5).- Р. 657-663.
- Huang J., Wang L., Prabakaran S. et al. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. // Molecular Psychiatry advance online publication 16 Chtober 2007.- doi: 10.1038/sj.mp.4002108